Evidence map›Paper›PMID 36350380›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

An exploration of the use of photobiomodulation for management of oral mucositis in children and young people undergoing cancer treatment in the UK.

Claudia Heggie, Kara A Gray-Burrows, Peter F Day, Bob Phillips

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07183267 (Reducing rAdiation aDverse Effects of dermatitIs and mucosAl inflammatioN Using Red Light Therapy), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07183267 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Reducing rAdiation aDverse Effects of dermatitIs and mucosAl inflammatioN Using Red Light Therapy

TypeinterventionalSponsorThe Christie NHS Foundation TrustRan2026 to 2028Enrolled248ConditionsRadio Dermatitis, Mucositis Oral, OesophagitisArmsPhotobiomodulation
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Claudia HeggiePaediatric Dentistry, University of Leeds, Leeds, UK. C.Heggie@leeds.ac.uk.ORCID http://orcid.org/0000-0002-5627-8357
Kara A Gray-BurrowsPaediatric Dentistry, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0002-1550-5066
Peter F DayPaediatric Dentistry, University of Leeds, Leeds, UK.ORCID http://orcid.org/0000-0001-9711-9638
Bob PhillipsPaediatric Oncology, University of York, York, UK.ORCID http://orcid.org/0000-0002-4938-9673
University of Leeds · GBUniversity of York · GB

Funding

Medical Research Council G0800472
6 · The paper itself

Abstract

purposeOral mucositis affects up to 80% of children and young people (CYP) receiving chemotherapy. This can result in pain, reduced oral intake and, in severe cases, hospitalisation for parental nutrition and pain relief. Photobiomodulation is recommended by multiple bodies for mucositis management for those undergoing cancer treatments. The current use of photobiomodulation within the UK, and the barriers and facilitators to implementation is unknown.

methodAn online mixed-methods survey was administered to representatives from the Children's Cancer and Leukaemia Group (CCLG) between October 2021 and March 2022. This explored: use of photobiomodulation, planned future use, barriers and facilitators to implementation and dental assessment. Quantitative data underwent descriptive statistics. Barriers and facilitators to the implementation of photobiomodulation were analysed using the Theoretical Domains Framework (TDF).

resultsAll UK CCLG centres responded (n = 20, a response rate of 100%). Two units in Scotland were delivering photobiomodulation. A further four units were planning to implement a service. Most units, 65% (n = 13) utilised specialist Paediatric Dentistry services for dental assessment. In the TDF analysis, five domains were most frequently populated: knowledge, skills, environmental context and resources, social influences, and social/professional role and identity.

conclusionPhotobiomodulation was only available in Scotland in two children's cancer units. Lack of knowledge and skills, and insufficient environmental resources were identified as barriers. Collaboration with paediatric dental services was identified as a facilitator. The establishment of a national network of Paediatric Dentists and Oncologists would promote collaboration to standardise protocols and to address the identified barriers to wider implementation of photobiomodulation.

Indexed as

NeoplasmsStomatitisAdolescentChildHumansPainSurveys and QuestionnairesUnited KingdomImplementationMucositisPaediatricPhotobiomodulationSupportive care

Identifiers

PMID36350380
PMCPMC9715443
OpenAlexW4308638329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.